Sebia

Our mission is to translate what happens in the human body into a comprehensible language to diagnose and treat chronic and metabolic diseases like cancer, obesity, aging, and depression. Sebia, a global leader in in-vitro diagnostics, provides tools and reagents for monitoring conditions such as multiple myeloma, diabetes, hemoglobinopathies, autoimmune, and rare diseases.

Based in Lisses, France, Sebia excels in capillary electrophoresis technology and the development of new tests and automated equipment, revolutionizing the diagnosis of metabolic inflammation through precise protein separation to better understand complex conditions.